reviewTop 1% cited
Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Mayo Clinic Proceedings · 2019 · Vol. 94(8) · pp. 1623–1640
Narjust Duma(Mayo Clinic in Arizona)Rafael Santana-Dávila(University of Washington Medical Center)Julian R. Molina✉(Mayo Clinic in Arizona)
Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research StudiesMedicineLung cancerOncologyCancerBiomarkerInternal medicineTargeted therapyChemotherapyChemoradiotherapyTreatment of lung cancer
MeSH terms
Carcinoma, Non-Small-Cell LungEducation, Medical, ContinuingFemaleHumansImmunotherapyLung NeoplasmsMalePneumonectomyPrognosisUnited StatesSurvival AnalysisChemotherapy, AdjuvantRisk AssessmentDisease-Free SurvivalEarly Detection of Cancer
Funding
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Merck
- AbbVie
- International Studies Association
Citations
2,172
FWCI
165.14
field-weighted impact
References
147
Percentile
100%
vs. same field & year
Citations per year
Cited by
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Frontiers in Oncology · 2020 · 388 citations
References
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
New England Journal of Medicine · 2011 · 10,776 citations
The National Lung Screening Trial: Overview and Study Design
Radiology · 2010 · 1,256 citations
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Science Translational Medicine · 2011 · 3,534 citations
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Nature Medicine · 2002 · 4,970 citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
European Journal of Cancer · 2008 · 28,935 citations
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
The Annals of Thoracic Surgery · 1995 · 2,996 citations
The blockade of immune checkpoints in cancer immunotherapy
Nature reviews. Cancer · 2012 · 13,550 citations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Journal of Clinical Oncology · 2013 · 3,181 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.